Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Stefan Wiemann
Affiliation
ORCID
Career Start Year
1988
Papers
195
H Index
55
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37745348
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer.
2023
38042915
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets.
2023
34972987
A Dual HiBiT-GFP-LC3 Lentiviral Reporter for Autophagy Flux Assessment.
Methods in Molecular Biology
2022
35655310
5'isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1.
J Exp Clin Cancer Res
2022
35895872
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.
Cancer Discov
2022
35625984
Disentangling ERBB Signaling in Breast Cancer Subtypes-A Model-Based Analysis.
Cancers
2022
35565214
High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome.
Cancers
2022
34911552
WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer.
Journal of Experimental and Clinical Cancer Research
2021
33476079
IFNβ1 secreted by breast cancer cells undergoing chemotherapy reprograms stromal fibroblasts to support tumour growth after treatment.
Mol Oncol
2021
33887215
Lipomatous Solitary Fibrous Tumors Harbor Rare NAB2-STAT6 Fusion Variants and Show Up-Regulation of the Gene PPARG, Encoding for a Regulator of Adipocyte Differentiation.
Am J Pathol
2021
33941614
Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors.
Cancer Research
2021
33497701
Gene Expression in Solitary Fibrous Tumors (SFTs) Correlates with Anatomic Localization and NAB2-STAT6 Gene Fusion Variants.
Am J Pathol
2021
34298736
Cancer-Associated Fibroblasts: Implications for Cancer Therapy.
Cancers
2021
33368291
Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy.
International Journal of Cancer
2021
32949162
Integrating proteomics into precision oncology.
Int J Cancer
2021
34863149
Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
BMC Cancer
2021
32684154
Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer.
BMC Cancer
2020
32198536
TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients.
Cancer Immunology, Immunotherapy
2020
32341238
Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation.
Am J Surg Pathol
2020
30664630
Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
Nat Commun
2019
30452682
Assembly of a parts list of the human mitotic cell cycle machinery.
J Mol Cell Biol
2019
30609375
Functional Proteomics of Breast Cancer Metabolism Identifies GLUL as Responder during Hypoxic Adaptation.
Journal of Proteome Research
2019
31094928
Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
Am J Surg Pathol
2019
31031757
Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Frontiers in Immunology
2019
31483270
Reconstruction of Different Modes of WNT Dependent Protein Networks from Time Series Protein Quantification.
2019
31105691
Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Frontiers in Immunology
2019
29261175
Identification of SLC20A1 and SLC15A4 among other genes as potential risk factors for combined pituitary hormone deficiency.
Genet Med
2018
30357946
PI3K: A master regulator of brain metastasis-promoting macrophages/microglia.
GLIA
2018
30248209
Long noncoding RNA HOTAIR is upregulated in an aggressive subgroup of gastrointestinal stromal tumors (GIST) and mediates the establishment of gene-specific DNA methylation patterns.
Genes Chromosomes Cancer
2018
30004628
TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer.
Molecular Oncology
2018
30524892
Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses.
OncoImmunology
2018
29396028
Cutis laxa, exocrine pancreatic insufficiency and altered cellular metabolomics as additional symptoms in a new patient with ATP6AP1-CDG.
Mol Genet Metab
2018
29391599
Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.
Oncogene
2018
29386221
Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.
Clinical Cancer Research
2018
28159925
miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A.
Oncotarget
2017
28771222
MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells.
Cell Death and Disease
2017
28688840
Impact of clinical exomes in neurodevelopmental and neurometabolic disorders.
Mol Genet Metab
2017
28553282
Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem Cells.
Frontiers in Immunology
2017
28630177
Integrated genome and transcriptome sequencing identifies a noncoding mutation in the genome replication factor <i>DONSON</i> as the cause of microcephaly-micromelia syndrome.
Genome Res
2017
28794264
Liquid-phase electron microscopy of molecular drug response in breast cancer cells reveals irresponsive cell subpopulations related to lack of HER2 homodimers.
Molecular Biology of the Cell
2017
28744850
The expression of hematopoietic progenitor cell antigen CD34 is regulated by DNA methylation in a site-dependent manner in gastrointestinal stromal tumours.
Int J Cancer
2017
29036586
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone.
Nucleic Acids Research
2017
29020998
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Breast Cancer Research
2017
28355565
Coordinated Pulses of mRNA and of Protein Translation or Degradation Produce EGF-Induced Protein Bursts.
Cell Reports
2017
29255182
A novel homozygous ARL13B variant in patients with Joubert syndrome impairs its guanine nucleotide-exchange factor activity.
Eur J Hum Genet
2017
27776010
Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas.
Am J Surg Pathol
2017
27502506
The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
BMC Genomics
2016
27013061
Environment-induced epigenetic reprogramming in genomic regulatory elements in smoking mothers and their children.
Mol Syst Biol
2016
27409399
Findings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences?
Expert Rev Mol Diagn
2016
26863915
Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern.
J Pathol
2016
1 - 50 of 195
Column Actions
Search
Recommended Authors
Collaborators
Rainer Pepperkok
Translational Lung Research Center Heidelberg, German Center for Lung Research
Co-authored papers
17
Abbas Agaimy
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Co-authored papers
14
Alexander Mehrle
Co-authored papers
12
Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers
12
Jeremy C Simpson
UCD Conway Institute of Biomolecular and Biomedical Science
Co-authored papers
11
Matthias Schlesner
University of Augsburg
Co-authored papers
9
Florian Hahne
1 Preclinical Safety, Novartis Institutes for Biomedical Research
Co-authored papers
7
Sabine M Klauck
Co-authored papers
6
Holger S??ltmann
German Cancer Research Center (DKFZ)
Co-authored papers
6
Wolfgang Huber
Technische Universitat Munchen
Co-authored papers
6
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers
5
Heiko Rosenfelder
Co-authored papers
5
Vladimir Kuryshev
Heidelberg University
Co-authored papers
5
Nagarajan Paramasivam
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers
5
Xavier Estivill
Sidra Medical Center
Co-authored papers
5
Winston Hide
Harvard Medical School
Co-authored papers
4
Christof von Kalle
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Co-authored papers
4
Osamu Ohara
Co-authored papers
4
Andreas von Deimling
Co-authored papers
4
Sumio Sugano
Co-authored papers
4
Jean Thierry-Mieg
Co-authored papers
3
Hans-Werner Mewes
Co-authored papers
3
Holger Fr??hlich
Bonn-Aachen International Center for IT (B-IT), University of Bonn
Co-authored papers
3
Danielle Thierry-Mieg
Co-authored papers
3
Dieter Weichenhan
German Cancer Research Center (DKFZ)
Co-authored papers
3
Takashi Gojobori
Co-authored papers
3
Christine M Freitag
Co-authored papers
3
Dawn Field
Biodiversity Institute, University of Oxford
Co-authored papers
3
Chris Lawerenz
German Cancer Research Center (DKFZ)
Co-authored papers
3
Yutaka Suzuki
Co-authored papers
3
1 - 30